Screening for Osteoporosis to Prevent Fractures
Top Cited Papers
Open Access
- 11 February 2025
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 333 (6) , 509-531
Abstract
The primary rationale for screening for osteoporosis is to identify persons who would benefit from pharmacotherapy to reduce the incidence and morbidity from fragility fractures, which are defined as fractures resulting from low-energy trauma (eg, a fall from standing height or less). In 2018, the US Preventive Services Task Force (USPSTF) recommended screening with bone measurement testing in women 65 years or older and in postmenopausal women younger than 65 years with increased risk of osteoporosis as determined by a formal clinical risk assessment tool.1 The evidence was insufficient for the USPSTF to assess the benefits and harms of screening in men (I statement).1 This update review evaluated the current evidence on screening to inform an updated recommendation by the USPSTF.Keywords
This publication has 211 references indexed in Scilit:
- Interventions to Prevent Falls in Community-Dwelling Older AdultsJAMA, 2024
- Screening for Osteoporosis to Prevent FracturesJAMA, 2018
- Repeat Bone Mineral Density Screening and Prediction of Hip and Major Osteoporotic FractureJAMA, 2013
- A Comparison of Prediction Models for Fractures in Older WomenArchives of internal medicine (1960), 2009
- Evaluating the Value of Repeat Bone Mineral Density Measurement and Prediction of Fractures in Older WomenArchives of internal medicine (1960), 2007
- Use of Clinical Prediction Rules in Detecting Osteoporosis in a Population-Based Sample of Postmenopausal WomenArchives of internal medicine (1960), 2005
- Alendronate Prevents Loss of Bone Density Associated With Discontinuation of Hormone Replacement TherapyArchives of internal medicine (1960), 2003
- Evaluation of Decision Rules for Referring Women for Bone Densitometry by Dual-Energy X-ray AbsorptiometryJAMA, 2001
- Upper Gastrointestinal Tract Safety Profile of AlendronateArchives of internal medicine (1960), 2000
- Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral FracturesResults From the Fracture Intervention TrialJAMA, 1998